Peptides are short chains of amino acids. Some are FDA-approved prescription drugs with labeled uses and manufacturing standards. Many peptides discussed in wellness and recovery circles are not FDA-approved. An advisory-committee recommendation is not approval, and compounding law is still narrower than social media suggests.
Helix Advanced Medicine will discuss both categories. We prefer an FDA-approved product when one exists for your problem. If you are asking about a peptide that is not approved, we will say so plainly, review what is and is not known, and decide together whether it belongs in your plan.
How we decide
- 01FDA-approved peptide drugs when they fit — the default when an approved medicine treats the condition.
- 02Off-label use of an approved drug when there is a documented rationale, consent, and follow-up.
- 03Non–FDA-approved peptides — only with informed consent, a physician visit, a written consent that names the product and its regulatory status, and a monitoring plan.
What we still will not do
- Inject or endorse patient-bought “research use only” vials from the internet as if they were clinic-grade care
- Promise tissue regeneration, anti-aging, or disease cure
- Skip labs or follow-up because a peptide is marketed as “natural”
- Present an advisory-committee vote as FDA approval or as a guarantee we can compound a given peptide tomorrow
If federal compounding rules later allow a specific peptide, we will say so and revisit sourcing. Until then, legality and pharmacy access remain part of the consent discussion—not a footnote. Approved metabolic peptides (such as labeled semaglutide or tirzepatide products) remain the core of care when weight or diabetes is the issue. Unapproved peptides are never a substitute for those drugs when the approved drug is the right treatment.
Who this may be for
- Patients who want an FDA-approved peptide with medical oversight
- Patients who have heard about other peptides and want a physician to explain status, evidence, and risk—not a sales pitch
- Patients willing to document consent if they still wish to consider a non-approved option after that discussion
What to expect
- 01Consultation — what you want treated and which peptides you have been offered
- 02Classification — approved / off-label / not approved
- 03Shared decision — proceed with an approved drug, decline unapproved therapy, or consider an unapproved option only after consent
- 04Follow-up — response, side effects, and whether to continue
